Corporate Strategy

Despite over a century of work to control or eradicate this disease, malaria continues to take its devastating toll, largely in developing nations.

According to the World Health Organization, there are currently no approved licensed malaria vaccines. Over 20 vaccine research projects are in clinical trials. Of these 20, the most advanced is in Phase 3 clinical trials, but is at best, 50% effective.

We are taking a new approach to vaccine development- one never tried before: an attenuated whole-parasite vaccine grown in culture. We believe that this targeted approach will be successful in finally creating a safe, affordable, and highly effective malaria vaccine.